Similarly, LAMA3 hypermethylation has been linked to chemotherapy resistance and poor prognosis in ovarian cancer, indicating that methylation patterns can serve as potential biomarkers for treatment outcomes [88]. This evidence concerns the gene LAMA3 and ovarian cancer.